1 Min Read
Jan 9 (Reuters) - Aralez Pharmaceuticals Inc -
* Aralez submits marketing authorization application to the European Medicines Agency for PA10040 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.